Here’s How Much You Would Have Made Owning Gilead Sciences Stock In The Last 20 Years
Gilead Sciences (NASDAQ:GILD) has outperformed the market over the past 20 years by 8.27% on an annualized basis producing an average annual return of 15.72%. Currently, Gilead Sciences has a market capitalization of $105.04 billion.
Why Pinterest Shares Jumped Around 14%; Here Are 69 Biggest Movers From Friday
Gainers
Quanergy Systems, Inc. (NASDAQ: QNGY) jumped 153.9% to close at $3.30 on Friday.
Check Out What Whales Are Doing With GILD
Someone with a lot of money to spend has taken a bullish stance on Gilead Sciences (NASDAQ:GILD).
And retail traders should know.
We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.
15 Global Psychedelics Executives To Keep An Eye On In 2022
As the global psychedelics industry booms, with companies going public, major financings being announced, and celebrities and big investors getting on board, Benzinga has decided to put together a list of some of the top executives in the space to keep an eye on.
Analysts Turn Bullish On Gilead After Q3 Earnings Surpass Expectations
Thursday, Gilead Sciences Inc (NASDAQ:GILD) reported Q3 revenue decreased 5% Y/Y to $7.04 billion, which beat average analyst estimates of $6.12…
Where Gilead Sciences Stands With Analysts
Over the past 3 months, 8 analysts have published their opinion on Gilead Sciences (NASDAQ:GILD) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.